Navigation Links
FDA Grants NeoVista's Request to Expand CABERNET Trial to 30 Sites in the U.S.
Date:4/17/2008

Agency Approves Expansion of Company's Phase 3 Study for Wet AMD after

90-day Review of Safety Data

FREMONT, Calif., April 17 /PRNewswire/ -- NeoVista, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted the company's request to expand the number of sites participating in its pivotal Phase 3 trial from 10 to 30 in the United States. The approved expansion of CABERNET (CNV Secondary to AMD Treated with BEta RadiatioN Epiretinal Therapy) trial, which seeks to evaluate the safety and efficacy of the company's novel epiretinal brachytherapy for the wet form of age-related macular degeneration (AMD), was dependent on the FDA's review of 90-day safety data, typical of new-to-market medical devices.

"With this expansion to 30 sites, we will not only be able to recruit more patients at a higher rate, taking us one step closer to commercialization in the United States, but it will also allow additional retina specialists to see the benefits of our novel therapy first-hand while treating their patients," said John N. Hendrick, President and CEO of NeoVista. "It's an exciting time at NeoVista with our recent CE Mark approval in the EU and the FDA approval of our trial expansion. We are getting closer and closer to seeing our investigational therapy become an approved treatment option for millions of patients worldwide afflicted with wet AMD."

CABERNET is a multicenter, randomized, controlled study that will enroll 450 subjects at clinical centers worldwide. The study will evaluate the safety and efficacy of NeoVista's epiretinal brachytherapy, delivered utilizing a limited vitrectomy, concomitant with two intravitreal injections of the FDA-approved antiangiogenic therapy Lucentis(R) (ranibizumab) versus Lucentis alone. For those enrolled in the trial arm utilizing brachytherapy, Lucentis is injected once at the time of the surgery and once again 30 days later. The co-primary endpoints in the CAB
'/>"/>

SOURCE NeoVista, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
2. Chinese SFDA Grants Immtech Fast Track Status
3. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
4. NTMir Announces Research Grants for Epidemiology and Household Water as Source of Infection
5. FDA Grants Approval to Extend U.S. Enrollment and Clinical Trial
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. FDA Grants Priority Review for ACIPHEX(R) (rabeprazole sodium) sNDA for Short-Term Treatment of GERD in Adolescents
8. FDA Grants Priority Review for PROMACTA(R) (eltrombopag)
9. Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis
10. U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences Claims
11. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... This September leading clinicians in orthodontics and ... for DOCtalk 2014 —a "Dynamic Orthodontic ... and private practitioner Dr. David Sarver , DOCtalk ... clinical and practice management efficiency and high quality patient ... to welcome fresh thinking and join a community of ...
(Date:7/23/2014)... 2014  Cardica, Inc. (Nasdaq: CRDC ) today ... fourth quarter and year ended June 30, 2014, on Thursday, ... host a conference call at 4:30 p.m. Eastern Time to ... company,s business. Conference Call Details To access the ... Eastern Time via phone, please dial 866-953-6859 from ...
(Date:7/23/2014)... , July 23, 2014  Silk Road ... the transcarotid treatment of intra- and extra-cranial cerebrovascular ... P. Wallace to the position of Chief ... lead the company,s Research and Development efforts across ... Prior to joining Silk Road ...
Breaking Medicine Technology:2014 DOCtalk Registration Now Open 22014 DOCtalk Registration Now Open 3Cardica to Announce Fiscal 2014 Fourth Quarter and Full Year Financial Results on Thursday, August 7, 2014 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 3
... Mass., Jan. 17, 2012 /PRNewswire-iReach/ -- Liberty ... Advanced training program for distributor packaging representatives. The program ... at the manufacturing industry " Do You Know What ... commented: "The Intercept Technology heavy duty barrier packaging is ...
... AUSTIN, Texas, Jan. 17, 2012   SpineSmith , a ... technologies in the field of regenerative medicine, is pleased to ... of PhDs. Dr. Murphy joins SpineSmith in ... new strategies for the isolation and application of autologous stem ...
Cached Medicine Technology:Intercept Technology Packaging Advanced Training Program Hosted by Liberty Packaging 2SpineSmith Adds Talented Scientist to Research and Development Team 2
(Date:7/23/2014)... (PRWEB) July 23, 2014 As the body ... more slowly resulting in old muscle being replaced by fatty ... excess fat in the belly region, the most dangerous area ... fat, actually surrounds the internal organs and circulates through the ... related conditions. , For this reason, Diet Doc’s staff ...
(Date:7/23/2014)... Raleigh, NC (PRWEB) July 23, 2014 ... is chemically similar to the yellow pigment in the ... destroy mesothelioma cells in the lab. To read ... , Scientists at Gazi University in Ankara, Turkey ... with both compounds before exposing them to two platinum-based ...
(Date:7/23/2014)... DC (PRWEB) July 23, 2014 ... some state-run insurance exchanges to come up with ... some of the myriad ways to accomplish this ... Services’s Inside Health Insurance Exchanges (HEX). , “We ... high” for state-run exchanges, Christopher Condeluci, an attorney ...
(Date:7/23/2014)... On July 19 and 20, the HearStrong Foundation ... and New York Giants Health & Fitness Expo 2014 at ... team, which included several hearing healthcare providers affiliated with ... and answered any questions that attendees had about their hearing ... sponsored by the NFL Players Association, HearStrong was proud to ...
(Date:7/23/2014)... Seattle, Wa (PRWEB) July 23, 2014 ... body sweats, it means that it is healthy enough ... is also useful for “washing out” harmful toxins and ... excretory system of the body just cannot do. ... prone to hyperhidrosis—or more commonly known as “excessive sweating”—are ...
Breaking Medicine News(10 mins):Health News:Diet Doc Medical Weight Loss Programs Announces Exclusive Diet Plans for Men that are Simple, Easy to Follow and Melt Dangerous Belly Fat 2Health News:Diet Doc Medical Weight Loss Programs Announces Exclusive Diet Plans for Men that are Simple, Easy to Follow and Melt Dangerous Belly Fat 3Health News:New Research Finds Pretreatment of Mesothelioma Cells with These Two Compounds Boosts Chemotherapy Response, According to Surviving Mesothelioma 2Health News:New Research Finds Pretreatment of Mesothelioma Cells with These Two Compounds Boosts Chemotherapy Response, According to Surviving Mesothelioma 3Health News:Industry Observers Tell AIS They Predict Changes to Exchange User Fees, Platforms 2Health News:Industry Observers Tell AIS They Predict Changes to Exchange User Fees, Platforms 3Health News:The HearStrong Foundation Provides Hearing Healthcare Awareness at the NBC 4 New York and New York Giants Health & Fitness Expo 2014 2Health News:Beat Your Sweating Demons Review | The Problem With Excessive Sweating and Solving it Naturally – Vinamy.com 2Health News:Beat Your Sweating Demons Review | The Problem With Excessive Sweating and Solving it Naturally – Vinamy.com 3
... 18 /PRNewswire-Asia-FirstCall/ -- China YCT International,Group Inc., (OTC ... a,leading company engaged in the business of developing, ... subsidiary, Shandong,Spring Pharmaceutical Co. Ltd, today announced its ... December 31, 2008. , , ...
... Professional Athletes Who Use the OmniPod System to Manage their ... of the country,s top professional cross-country skiers, is competing on ... month. As a world-class athlete, Freeman intends to medal, ... I diabetes. Diabetes doesn,t keep Freeman from performing at ...
... Innovations in the Past 30 Years - Quantros President and Chief ... last week, discussing the importance of using technology to track and ... , ... San Francisco, CA (PRWEB) February 17, 2009 - ...
... International Effort to Combat Rare Diseases That Collectively Effect 1 in 10 ... ... 2009 -- Students at Albany High School in Albany, California, are asking ... support the first annual World Rare Disease Day, an international event being ...
... Growth is expected in Australian pharmaceuticals and ... accounted for 80 percent or $258.6 million and will continue ... same period, life sciences spending on IT accounted for $64.6 ... pharmaceuticals and life sciences market. It is expected to ...
... based Renaissance Laser & Vein Institute eliminates varicose ... OAKS, Calif., Feb. 17 Southern California based ... easy and effective method for eliminating painful and ... proper vein structure is a common problem. ...
Cached Medicine News:Health News:China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results 2Health News:China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results 3Health News:China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results 4Health News:China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results 5Health News:China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results 6Health News:China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results 7Health News:China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results 8Health News:China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results 9Health News:Elite Skier Uses OmniPod(R) Insulin Management System at World Championships 2Health News:Quantros President Appears on National TV Promoting Patient Safety 2Health News:Albany High School Students Unite To Raise Awareness and Funds For World Rare Disease Day 2009 2Health News:Albany High School Students Unite To Raise Awareness and Funds For World Rare Disease Day 2009 3Health News:Frost & Sullivan: Australian Pharmaceuticals and Life Sciences IT Market Is Still Growing 2Health News:Renaissance Laser & Vein Institute (LaserandVeinclinic.com) Provides Top Notch 'Varicose Vein Treatment' 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: